Prioritizing simple administrative measures to ensure appropriate tuberculosis infection control
- D Chemtob1
© Chemtob; licensee BioMed Central Ltd. 2011
Published: 29 June 2011
Introduction / objectives
For reducing Tuberculosis (TB) transmission, early diagnosis and prompt treatment of TB patients should be completed by implementing TB Infection Control (TB-IC) measures. Our objective is to analyze the TB-IC Global Policy, its current implementation status and strategies to scale-up TB-IC measures at country level.
Analysis of the TB-IC Global Policy, and description of strategies and challenges for scaling-up TB-IC measures at country level.
“WHO Policy on TB-IC in Health-Care Facilities, Congregate Settings and Households” (2009) recommended the implementation of a set of measures (administrative, personal protection, environmental). Since, WHO and other partners have been engaged in a series of actions, including Regional/National trainings of hundreds of professionals and Technical Assistance to countries. A new indicator for monitoring TB-IC and the cost analysis for a worldwide implementation have also been integrated into the "Global Plan to Stop TB 2011-2015". However, TB-IC is still in a preliminary implementation phase in most of the countries. Scaling-up should therefore prioritize the implementation of simple and economical administrative measures; e.g. identifying potentially infectious cases (triage), separating them, and assuring health care worker protection. By embedding TB-IC plans into broader ones (i.e. MDR-TB, HIV, Health System Strengthening, general IC), TB-IC measures should progressively be incorporated into national plans funded by major donors. Preliminary data on country implementation, opportunities and bottle-necks will be presented.
Using first simple and economical TB-IC measures, together with embedding TB-IC within broader plans, should contribute to their step-wise implementation. This should also ultimately impact positively the country TB burden.
Disclosure of interest
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.